Tag: Clinical trials
India is emerging as a favourable destination to conduct clinical trials:...
Biopharma can benefit from the critical enablers of innovation in the private healthcare system in India
“Our lead antibacterial asset is undergoing first-in-human phase-I clinical trials”
Dr Vasan Sambandamurthy, Senior Vice President, Bugworks Research India shares his views on the current biotech and startup scenario, his company’s journey so far, R&D initiatives and future outlook
BioVoice eMagazine March 2023 Issue 3 Volume 4
Click to Read: March 2023 Edition of BioVoice eMagazine
The Cover Story, "The Torchbearers of Indian bioscience- Profiling India’s Top 20 Promising Bioscience Innovators" in the...
BioVoice eMagazine February 2023 Issue 2 Volume 4
Click to Read: February 2023 Edition of BioVoice eMagazine
The Cover Story in the February 2023 issue focuses on the ambitious US$ 300 billion bioeconomy...
India developed four indigenous vaccines in just two years: Dr Jitendra...
DBT through “Mission COVID Suraksha”, delivered four vaccines, augmented the manufacturing of Covaxin
NAFLD clinical trial activity catching up in China, mostly driven by...
China has the highest number of clinical trials that were initiated in NAFLD in the APAC region over the past decade
Wolters Kluwer celebrates 30 years of UpToDate, the industry-leading clinical decision...
Studies have demonstrated that UpToDate helps improve decision-making leading to higher quality of care and improved health outcomes
Zydus achieves positive Phase 2 Proof-of-Concept of NLRP3 inhibitor, ZYIL1 in...
The company is now planning to conduct further pivotal clinical trials and is committed to develop ZYIL1 for patients living with CAPS and other chronic inflammatory diseases
Parexel expands patient access to clinical trials through new community alliance...
Alliances with CVS Health and Javara further embed clinical research into the community healthcare setting, expanding access to patient populations across the U.S to increase diversity in clinical trials
THSTI to help Vietnam based Nanogen to develop COVID vaccine
The team at Translational Health Science and Technology Institute (THSTI) will evaluate a vaccine candidate, named NanoCovax developed by Nanogen Pharmaceutical Biotechnology.............................